Company / Operating Margin
Caribou Biosciences, Inc. Operating Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-1329.4%
FY2025
5-year range
-1329.4% / -336.6%
FY2021-FY2025
Trend
-294.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -295% YoY in FY2025, a notable deviation from the 4-year average annual change of -67%.
Based on SEC 10-K filings.
-1329.4% in FY2025 with a 3-year CAGR of -631.5%.
Declined from -768.2% to -1329.4% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -631.5pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin decreased 294.9% year-over-year.
- Peak operating margin was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.99 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -1329.4% | -294.9% |
| FY2024 | -336.6% | +56.2% |
| FY2023 | -768.2% | -10.1% |
| FY2022 | -697.8% | -17.7% |
| FY2021 | -592.7% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026